Meet Our Leadership Team
Our leadership team is tirelessly committed to disrupting cancer’s energy by bringing Misetionamide to market.
Clinical Opinion Leaders & Scientific Advisors

LISA GUTTMAN
Head, Clinical Operations

HANS POEHLER
Head, Pharmacology

ALEXANDER SMITH
Head, CMC & Quality

BEN STEINMETZ
Chief Commercial Officer

KATHRYN Martin, PharmD
Head, Scientific & Regulatory
Communications

Duane Sofia, PhD
Head, Non-Clinical Research
Collaborators



+1.610.922.1910
Copyright © 2025 Panavance Therapeutics Inc.
Our Home
About
Resources
Participate